520 related articles for article (PubMed ID: 9342184)
21. Regulated expression of homeobox genes Msx-1 and Msx-2 in mouse mammary gland development suggests a role in hormone action and epithelial-stromal interactions.
Friedmann Y; Daniel CW
Dev Biol; 1996 Jul; 177(1):347-55. PubMed ID: 8660900
[TBL] [Abstract][Full Text] [Related]
22. Localization and quantification of Wnt-2 gene expression in mouse mammary development.
Bühler TA; Dale TC; Kieback C; Humphreys RC; Rosen JM
Dev Biol; 1993 Jan; 155(1):87-96. PubMed ID: 8416847
[TBL] [Abstract][Full Text] [Related]
23. Differential keratin gene expression in developing, differentiating, preneoplastic, and neoplastic mouse mammary epithelium.
Smith GH; Mehrel T; Roop DR
Cell Growth Differ; 1990 Apr; 1(4):161-70. PubMed ID: 1707299
[TBL] [Abstract][Full Text] [Related]
24. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
[TBL] [Abstract][Full Text] [Related]
25. Wnt-1 and int-2 mammary oncogene effects on the beta-catenin pathway in immortalized mouse mammary epithelial cells are not sufficient for tumorigenesis.
Hollmann CA; Kittrell FS; Medina D; Butel JS
Oncogene; 2001 Nov; 20(52):7645-57. PubMed ID: 11753642
[TBL] [Abstract][Full Text] [Related]
26. Analysis of tenascin mRNA expression in the murine mammary gland from embryogenesis to carcinogenesis: an in situ hybridization study.
Kalembey I; Yoshida T; Iriyama K; Sakakura T
Int J Dev Biol; 1997 Aug; 41(4):569-73. PubMed ID: 9303344
[TBL] [Abstract][Full Text] [Related]
27. Mammary tumor development in MMTV-c-myc/MMTV-v-Ha-ras transgenic mice is unaffected by osteopontin deficiency.
Feng F; Rittling SR
Breast Cancer Res Treat; 2000 Sep; 63(1):71-9. PubMed ID: 11079161
[TBL] [Abstract][Full Text] [Related]
28. Induction of expression of osteopontin (OPN; secreted phosphoprotein) in metastatic, ras-transformed NIH 3T3 cells.
Chambers AF; Behrend EI; Wilson SM; Denhardt DT
Anticancer Res; 1992; 12(1):43-7. PubMed ID: 1567180
[TBL] [Abstract][Full Text] [Related]
29. Developmental stage determines the effects of MYC in the mammary epithelium.
Blakely CM; Sintasath L; D'Cruz CM; Hahn KT; Dugan KD; Belka GK; Chodosh LA
Development; 2005 Mar; 132(5):1147-60. PubMed ID: 15689376
[TBL] [Abstract][Full Text] [Related]
30. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
[TBL] [Abstract][Full Text] [Related]
31. Chromosomal mapping and quantitative analysis of estrogen-related receptor alpha-1, estrogen receptors alpha and beta and progesterone receptor in the bovine mammary gland.
Connor EE; Wood DL; Sonstegard TS; da Mota AF; Bennett GL; Williams JL; Capuco AV
J Endocrinol; 2005 Jun; 185(3):593-603. PubMed ID: 15930184
[TBL] [Abstract][Full Text] [Related]
32. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
Happ B; Hynes NE; Groner B
Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
[TBL] [Abstract][Full Text] [Related]
33. Expression of osteopontin messenger RNA and protein in rheumatoid arthritis: effects of osteopontin on the release of collagenase 1 from articular chondrocytes and synovial fibroblasts.
Petrow PK; Hummel KM; Schedel J; Franz JK; Klein CL; Müller-Ladner U; Kriegsmann J; Chang PL; Prince CW; Gay RE; Gay S
Arthritis Rheum; 2000 Jul; 43(7):1597-605. PubMed ID: 10902765
[TBL] [Abstract][Full Text] [Related]
34. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis.
Iavnilovitch E; Groner B; Barash I
Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367
[TBL] [Abstract][Full Text] [Related]
35. OZF gene expression in growing mouse and rabbit mammary gland and in rabbit mammary cells and Nb2 cells under prolactin action.
Puissant C; Lennaouar M; Le Chalony C; Goubin G; Houdebine LM
Biochem Mol Biol Int; 1996 Mar; 38(3):543-52. PubMed ID: 8829614
[TBL] [Abstract][Full Text] [Related]
36. A transcriptional repressor of osteopontin expression in the 4T1 murine breast cancer cell line.
Gao C; Mi Z; Guo H; Wei J; Wai PY; Kuo PC
Biochem Biophys Res Commun; 2004 Sep; 321(4):1010-6. PubMed ID: 15358129
[TBL] [Abstract][Full Text] [Related]
37. Caprine uterine and placental osteopontin expression is distinct among epitheliochorial implanting species.
Joyce MM; González JF; Lewis S; Woldesenbet S; Burghardt RC; Newton GR; Johnson GA
Placenta; 2005; 26(2-3):160-70. PubMed ID: 15708117
[TBL] [Abstract][Full Text] [Related]
38. Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer.
Zhu Y; Denhardt DT; Cao H; Sutphin PD; Koong AC; Giaccia AJ; Le QT
Oncogene; 2005 Sep; 24(43):6555-63. PubMed ID: 16007184
[TBL] [Abstract][Full Text] [Related]
39. Expression of osteopontin in human glioma. Its correlation with the malignancy.
Saitoh Y; Kuratsu J; Takeshima H; Yamamoto S; Ushio Y
Lab Invest; 1995 Jan; 72(1):55-63. PubMed ID: 7837791
[TBL] [Abstract][Full Text] [Related]
40. Proteomic analysis of the mouse mammary gland is a powerful tool to identify novel proteins that are differentially expressed during mammary development.
Davies CR; Morris JS; Griffiths MR; Page MJ; Pitt A; Stein T; Gusterson BA
Proteomics; 2006 Nov; 6(21):5694-704. PubMed ID: 17022101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
